Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chemomab Therapeutics Ltd ADR (NQ: CMMB ) 0.9849 +0.0174 (+1.80%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 24,518 Open 0.9300 Bid (Size) 0.9500 (49) Ask (Size) 1.000 (25) Prev. Close 0.9675 Today's Range 0.9300 - 0.9849 52wk Range 0.4200 - 1.500 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis June 18, 2024 From Chemomab Therapeutics Via GlobeNewswire Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference June 06, 2024 From Chemomab Therapeutics Via GlobeNewswire Performance YTD +83.13% +83.13% 1 Month -20.57% -20.57% 3 Month +26.27% +26.27% 6 Month +85.83% +85.83% 1 Year -21.21% -21.21% More News Read More Chemomab Therapeutics to Participate in Upcoming Scientific Conferences May 17, 2024 From Chemomab Therapeutics Via GlobeNewswire CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q1 2024 May 09, 2024 Via InvestorPlace Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From Chemomab Therapeutics Via GlobeNewswire Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule May 08, 2024 From Chemomab Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session May 06, 2024 Via Benzinga Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference May 02, 2024 From Chemomab Therapeutics Via GlobeNewswire Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update April 24, 2024 From Chemomab Therapeutics Via GlobeNewswire Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis April 18, 2024 From Chemomab Therapeutics Via GlobeNewswire Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024 April 02, 2024 From Chemomab Therapeutics Via GlobeNewswire Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis March 25, 2024 From Chemomab Therapeutics Via GlobeNewswire CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023 March 07, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 22, 2024 Via Benzinga Earnings Scheduled For March 7, 2024 March 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session February 20, 2024 Via Benzinga What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday? February 20, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket January 18, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday January 18, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 29, 2023 Via InvestorPlace Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session November 16, 2023 Via Benzinga Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket November 16, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 16, 2023 Via InvestorPlace Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook November 15, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
